Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01670500
What this trial is testing

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

Who this might be right for
Breast Cancer
Beth Israel Deaconess Medical Center 118
Testing effectiveness (Phase 2)Study completedNCT00499122
What this trial is testing

NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer

Who this might be right for
Breast Cancer
University of Miami 41
Testing effectiveness (Phase 2)Ended earlyNCT00977379
What this trial is testing

Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis

Who this might be right for
Breast Cancer
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)UnknownNCT00801411
What this trial is testing

Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 318
Testing effectiveness (Phase 2)WithdrawnNCT05177796
What this trial is testing

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+10 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00111787
What this trial is testing

Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Ended earlyNCT00347438
What this trial is testing

Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Chicago 18
Not applicableWithdrawnNCT01018251
What this trial is testing

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Who this might be right for
Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)
Abramson Cancer Center at Penn Medicine
Not applicableUnknownNCT01038258
What this trial is testing

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

Who this might be right for
Invasive Ductal CarcinomaLobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 80
Not applicableActive Not RecruitingNCT04009148
What this trial is testing

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

Who this might be right for
BRCA-Mutated Ovarian CarcinomaBRIP1 Gene MutationMSH2 A636P+5 more
NYU Langone Health 118
Not applicableStudy completedNCT06910917
What this trial is testing

The Effect of Roy Adaptation Model-Based Nursing Interventions on Psychological Resilience and Psychosocial Adjustment in Newly Diagnosed Breast Cancer Patients: A Randomized Controlled Trial

Who this might be right for
Breast CancerPsychosocial AdaptationPsychological Resilience
Aytuğ Türk 44
Not applicableStudy completedNCT04158258
What this trial is testing

Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,907
Not applicableStudy completedNCT04006626
What this trial is testing

18F-FES PET/CT's Additional Clinical Value in ER+ BC

Who this might be right for
Breast Cancer
Fudan University 19
Not applicableEnded earlyNCT01176838
What this trial is testing

A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients

Who this might be right for
Newly Diagnosed Breast Cancer
Wake Forest University 20
Early research (Phase 1)Study completedNCT02391194
What this trial is testing

Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery

Who this might be right for
Breast Cancer
Avelas Biosciences, Inc. 27
Not applicableStudy completedNCT05011409
What this trial is testing

Prevalence of Depression and Anxiety Among Breast Cancer Patients

Who this might be right for
DepressionAnxietyBreast Cancer
Kazakh Medical University of Continuing Education 162
Not applicableStudy completedNCT01722851
What this trial is testing

Circulating miRNAs.

Who this might be right for
Breast CancerNewly Diagnosed Breast CancerRecurrent Breast Cancer
Cancer Trials Ireland 255
Not applicableNot Yet RecruitingNCT07434817
What this trial is testing

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

Who this might be right for
Breast Cancer FemalesNewly Diagnosed Breast Cancer
University of Colorado, Denver 200
Not applicableActive Not RecruitingNCT03429907
What this trial is testing

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer

Who this might be right for
Malignant Neoplasm of Breast
M.D. Anderson Cancer Center 62
Next Page